Cultured porcine heart valves secrete a factor that induces cells to degrade their extracellular matrix. This activity was routinely monitored by measuring the release of glycosaminoglycans from proteoglycan in cultured bovine nasal cartilage. It was observed that factor-mediated matrix degradation was dose dependent and required live target cells, while factor production by valves was inhibited by cycloheximide and declined with reduced cell viability. The effect of various steroidal and nonsteroidal anti-inflammatory drugs on the production and activity of the factor is discussed with reference to similar cytokines. It is concluded that there is a close similarity between the cardiac catabolic factor described here and catabolin, a protein isolated from porcine synovia and leukocytes, as shown by the neutralization of biological activity with antisera raised to porcine catabolin (interleukin-1).
D ATA from several groups suggest that extracel-I lular matrix degradation in many chronic degenerative diseases may be mediated by the cells residing in those tissues.'" 3 Evidence points toward these cells being stimulated in some way to produce and secrete soluble extracellular messengers, which then interact with indigenous cells inducing them to degrade their extracellular matrix. 1 " 5 Such factors have been isolated from a variety of soft connective tissues in culture 126 " 8 as well as cultured cells such as fibroblasts, 9 monocytes, 810 macrophages,"" 13 and lymphocytes. 14 In addition, products from mononuclear phagocytes have been shown to greatly enhance the secretion of collagenase, neutral proteases, and lysosomal enzymes, 13 " 16 all of which have been implicated in extracellular matrix degradation. 17 Therefore, it seems that a wide range of cells and tissues, principally of mesodermal origin, are capable of producing similar activities. 3 -618 Recently, a factor derived from cultured porcine mitral valves was found to stimulate both the degradation of proteoglycan in bovine nasal cartilage and collagen in the mitral valves themselves. 6 It was suggested that such a factor could play a part in the appearance of defective connective tissue matrices seen in valve abnormalities, such as chronic rheumatic and floppy mitral valves. These experiments inferred that this cardiac catabolic factor (CCF) possessed properties simi-after, it was changed every other day for two weeks, with all samples being frozen prior to assay for the catabolic activity. Valves were also cultured in medium supplemented with either hydrocortisone succinate (0.01-10.0 /xg/ml), methylprednisolone succinate (0.01-1.0 /Ag/ml), benoxaprofen (25 ju,g/ml, 50 pig/ ml), ibuprofen (50 /ng/ml), or indomethacin (1 FIM or 10 /JM). Valve minces were also cultured in the presence of cycloheximide at 5, 10, or 20 /xg/ml DMEM to assess whether the inhibition of protein synthesis alters the synthesis and secretion of CCF.
Preparation of Chromatofocused Catabolin
The partial purification of synovial catabolin to the stage of chromatofocusing was carried out according to the procedure described by Saklatvala et al. 8 -22 In this case, 4 liters of conditioned synovial medium was adjusted to pH 8.5 and mixed with a slurry of DEAEcellulose, DE 52, which had previously been equilibrated with 20 mM glycine/HCl buffer pH 8.5. The slurry was then applied to a column, washed with excess equilibration buffer, and eluted with the same buffer, containing 0.13 M NaCl in a stepwise fashion. Fractions exhibiting activity in the bioassay were pooled, concentrated over an Amicon PM10 membrane, and applied to a calibrated column of Ultrogel AcA 54 (1.5 X 90 cm). The column was eluted with phosphate buffered saline pH 7.4. As before, the active fractions were pooled and concentrated, and the buffer changed to 25 mM histidine-HCl pH 6.2. The sample was applied to an equilbrated column of Polybuffer PBE 94 exchanger (1.5 x 30 cm) and eluted using a linear pH gradient over the range 4 to 7. The active fractions were pooled for use in the assays.
Bioassay for CCF Activity
The secretion of CCF from cultured valves was monitored by measuring the release of glycosaminoglycans in a bovine nasal disc assay that was modified from the original protocol of Dingle and associates. 2 Small cartilage discs (1x3 mm) were prepared from perichondrium-free bovine nasal septum cartilage. The cartilage discs were preincubated at 37° C in DMEM + 5% fetal calf serum (FCS) for 24 hours before being distributed one disc per well, inamicrotiterplate, each well containing 200 /xl of fresh medium. Conditioned medium from cultured heart valves was diluted with DMEM, to give a range of concentrations for dose-response curves, and FCS was then added to a final concentration of 5%. All the bioassays were conducted in the presence of 0.1 /xg/ml hydrocortisone succinate to suppress the endogenous breakdown of cartilage proteoglycan. 18 Routinely, assays were performed in quintuplicate with a negative and positive control, consisting of discs cultured in unsupplemented medium and medium containing 20 ^il/ml chromatofocused catabolin respectively. Occasionally, discs were frozen and thawed repeatedly before culture to provide an additional dead tissue control for assessment of proteoglycan degradation as a result of autolysis. After 5 days incubation, the discs were removed and hydro-lysed with papain. 23 Both the digests and medium were assayed for chondroitin sulphate using a colorimetric assay for 1,9-dimethyl-methylene blue, as described by Farndale et al. 24 For this assay, standard curves were prepared with purified shark chondroitin sulphate (ChSO 4 ). The release of ChSO 4 into the culture medium from cartilage discs was expressed as 
Assessment of Cell Viability in Valve Explants
To assess the viability of cultured valves, explants were sampled at various intervals of culture as follows. Explants were exposed to a 4-hour pulse with 1 /iCi/ml C K -L-tyrosine (530 mCi/mmol), and incorporation of the label into noncollagenous protein was measured as described by Henney et al. 23 Tissue was homogenized in 0.5 M acetic acid and an aliquot of the homogenate was extracted with 20% trichloroacetic acid (TCA) for 30 minutes at 90° C. This treatment solubilizes the collagen and precipitates the hot TCA insoluble noncollagenous protein. This suspension was centrifuged in an Eppendorf microcentrifuge, the pellet washed in 5% TCA, and the precipitate collected on a 0.45 /xm Millipore filter. The filters were then dried and counted directly in a liquid scintillation counter. The remainder of the original homogenate was lyophilized and assayed for protein according to Lowry et al. 26 Protein synthesis was expressed as dpm C l4 -L-tyrosine incorporated into hot TCA insoluble material per milligram protein ± SEM. Lactate dehydrogenase was measured simultaneously in these cultures as described by Bergmeyer. 27 
Results

Bioassay for CCF Activity
The conditioned medium from cultured porcine heart valves successfully induced degradation of proteoglycan in the nasal cartilage bioassay. Over the 5day culture period, medium from 3-day valve cultures induced the release of nearly 70% of the total chondroitin sulphate from the cartilage discs ( Figure 1 ); the kinetics of the glycosaminoglycan release closely resembled those generated by synovial catabolin in a parallel experiment. In contrast, the cumulative release of chondroitin sulphate from unstimulated live and stimulated dead cartilage disc controls over the same period amounted to less than 20%. It was observed that proteoglycan degradation induced by CCF was dose dependant ( Figure 2 ) and unaffected by the presence of 0.1 /xg/ml hydrocortisone succinate. However, the inclusion of the steroid in the bioassay consistently reduced the level of endogenous proteoglycan degradation, as illustrated by the reduction from approximately 27-20% release from discs cultured in the absence of CCF ( Figure 2 ). The way in which cortisol inhibits this breakdown is unclear, but this result concurs with earlier observations. 18 Frozen-thawed cartilage discs exposed to increasing concentrations of CCF did not respond in the same way, suggesting that 
FIGURE I. Proteogtycan release from cultured bovine nasal discs in response to (A) chromatofocused porcine synovial catabolin (20 ixl/ml), (9) a I • 1 dilution of 3-day porcine heart valve conditioned medium, (o) DMEM plus 5% fetal calf serum.
Frozen-thawed nasal cartilage (A) was also exposed to 20 fjd/ml chromatofocused porcine synovial catabolin. All assays were conducted in quintuplicate in the presence of 0.1 /Jig/ml hydrocortisone; each value represents the mean cumulative release of glycosamtnoglycan ± SEM.
the factor was not activating latent enzymes that may have been released from the chondrocytes. These findings are consistent with the reported behavior of catabolin. 1418
Production of CCF
Data from four separate experiments show that porcine valves produce substantial amounts of CCF over the first 5 days of culture in serum-free medium ( Table   0   0 
CCF Medium Dilutions (ml/ml DMEM)
FIGURE 2. Dose-dependent CCF-mediated degradation of bovine nasal cartilage proteoglycan. Assays were conducted in quintuplicate in the presence (O) or absence (*) of hydrocortisone (O.I /jig/ml). CCF medium was prepared from valves cultured for 3 days in serum-free DMEM diluted with DMEM plus fetal calf serum. Controls consist of medium from cultured frozen-thawed heart valves (A).
I); thereafter, production of CCF declines progressively. By Day 7, production was only 30-45% of that at Day 3, and by Day 13 it had diminished to background and negative control levels. This pattern of CCF production could arise either from a gradual release of stored product into the medium or from a concomitant decline in cell viability impairing active production. To determine whether the decline in CCF production was related to reduced viability of the valve cultures, explants were labelled at •Porcine valves (10% W/V) were cultured in serum-free DMEM for the indicated period. tAll assays were conducted in quintuplicate on bovine nasal discs in the presence of 0.1 ^ig/ml hydrocortisone.
Positive controls were run in the presence of chromatofocused synovial catabolin at a concentration of 20 DMEM.
§Blanks consist of bovine discs cultured in DMEM + 5% fetal calf serum and 0.1 ng/m\ hydrocortisone. Days In Culture 13 various intervals with C 14 -L-tyrosine and the degree of cell death estimated by monitoring lactate dehydrogenase (LDH) activity. As is shown in Figure 3 , the valve minces incorporated significant amounts of the labelled amino acid into protein over the first 5 days of culture; thereafter, there was a rapid decline in levels of protein synthesis. This result is consistent with the observations in an earlier report of the metabolic behavior of cultured heart valves. 28 Similarly, cellular LDH activity declined with prolonged culture. If the pattern of CCF production is superimposed on these results (Figure 3 ), it can be seen that the decline in production closely follows the pattern of diminishing cell viability.
To study further how CCF production is influenced by active protein synthesis, valve minces were incubated in the presence of cycloheximide and production of the factor monitored. At low concentrations, cyclo- heximide significantly reduced the production of CCF, but did not abolish it until the fifth day of culture (Table 2) , while at higher concentrations the effect on production was immediate. It was observed that a 24hour exposure to 5 /xg/ml cycloheximide reduced protein synthesis by 45%; whereas a 4-hour exposure to 10 and 20 /xg/ml doses reduced protein synthesis by 80 and 90% respectively (data not shown). This seems to suggest that production of CCF is dependent on continued active protein synthesis, as is synovial catabolin. 29
Effects of Glucocorticoids oh CCF Production
It has been reported that, although the production of catabolin is inhibited by steroids, its action on cartilage is unaffected by their presence. 1821 Porcine valve minces were cultured in the presence of hydrocortisone succinate and methylprednisolone succinate to see •Porcine valves (10% W/V) were cultured in serum-free DMEM plus cycloheximide for specific intervals. The medium was dialyzed against DMEM for 24 hours (3 x) to remove the antibiotic and diluted 1:1 with DMEM + 10% fetal calf serum before culture with bovine nasal discs.
tAll assays were conducted in quintuplicate in the presence of 0.1 //.g/ml hydrocortisone. Each value represents the mean ± SD. + Positive controls were conducted in the presence of chromatofocused synovial catabolin (20 /xl/ml). §Bovine nasal discs were also cultured in DMEM plus 5% fetal calf serum for 5 days. All assays were conducted in quintiuplicate in the presence of 0.1 /ig/ml hydrocortisone succinate. Each value represents the mean ± SD.
•Porcine valves (10% W/V) were cultured in serum-free DMEM supplemented with hydrocortisone succinate for 1 to 13 days. The medium was collected and dialyzed against DMEM (3 x ) for 24 hours before being diluted 1:1 with DMEM plus 10% fetal calf serum.
tPositive controls were cultured in the presence of chromatofocused catabolin (20 /il/ml) instead of CCF. tBovine nasal discs were also cultured in DMEM + 5% fetal calf serum for 5 days.
whether the production of CCF was similarly impaired. Table 3 shows that CCF production was unaffected by 0.1 /xg/ml hydrocortisone but was increasingly inhibited by the presence of pharmacological doses (1 and 10 /Ag/ml) of the drug. This result contrasts with the reported effect of cortisol on the production of catabolin-like activity by bovine sclera and porcine synovium, 1830 where a dose of 0.1 /Lig/ml suppressed production significantly. The reason for the discrepancy in these observations is unclear, but it may be explained by differences in the structure and composition of the tissues. Methylprednisolone was an order of magnitude more effective than hydrocortisone, abolishing CCF production more rapidly and at a much lower dose (Figure 4 ). The pattern of inhibition of CCF production by this steroid closely resembled that reported for inhibition of catabolin production by synovia. 21 A further similarity between CCF and catabolin is that, in general, neither steroid significantly impaired the activity of the cardiac factor when tested in the cartilage bioassay (data not shown); only methylprednisolone used at 10 /xg/ml showed signs of slight inhibition. But, this dose represents 40 times the peak plasma level achieved therapeutically with this drug 21 and, therefore, represents an excessive dose.
Effect of Nonsteroidal Anti-inflammatory Drugs (NSAIDS)
The NSAIDS used in this study had no effect on the production or action of CCF. This contrasts with the reported action of benoxaprofen on synovia] tissue: Dingle 31 has shown that benoxaprofen used at 30 /Ltg/ml resulted in an eightfold increase in catabolin production and that the production of the factor was Days In Culture
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BJoaasay controls prolonged well beyond the peak level achieved in its absence. In the same study, indomethacin, used at concentrations of 0.36-35.8 /i.g/ml, did not induce the same response, and neither affected catabolin-mediated cartilage degradation.
Neutralization of Biological Activity by Antisera
Preincubation of conditioned media with a 1:200 dilution of antiserum raised to the acidic form of porcine IL-1 32 resulted in the abolition of biological activity in the cartilage bioassay (Table 4 ). Similar results were obtained with chromatofocused catabolin, and no interference was observed when the two factors were incubated with nonimmune rabbit serum alone. These findings concur with similar work on a human valve factor (Henney and Decker, unpublished work) and the effect of the antiserum in neutralizing CCF activity in the thymocyte assay. 33 In experiments with porcine IL-1, the antiserum was effective at doses as low as 1:10,000, 32 whereas in our studies the inhibitory effect diminished rapidly at higher dilutions. The reason for this difference may be that contaminants present in partially pure material may have interfered with efficient formation of antigen-antibody complexes.
Discussion
The present observations clearly confirm the earlier report* that minced porcine heart valves, cultured under conditions of serum deprivation, produce a factor that stimulates cells to degrade proteoglycan. It appears that CCF is actively synthesized and secreted by the valves, as its production is closely linked to cell viability ( Figure 3 ) and can be suppressed by levels of cycloheximide that inhibit protein synthesis ( Table 2) .
The secretion of similar catabolic factors by a variety of tissues and cells has been reported. 3-5-6 -18 -34 Data accumulated from these investigations have implicated these soluble factors as mediators of various chronic degenerative diseases, including several inflammatory arthritides. 5 It is conceivable that CCF is another member of what appears to be a family of catabolic pro- Chromatofocused CCF and catabolin were dialysed against culture medium and then supplemented with either anti-porcine IL-1 or nonimmune rabbit serum. All culture media were preincubated at 37° C for 18 hours before addition of cartilage discs for the bioassay as described by Decker et al. 33 Values for chrondroitin sulphate released are means ± SEM for quintuplicate assays. teins, which may be involved in the destruction of extracellular matrix in a variety of cardiac valve abnormalities, such as chronic rheumatic and floppy mitral valves.
The experiments presented here demonstrate that many of the properties of CCF are similar to those of catabolin, a protein that has recently been purified to homogeneity from porcine leukocytes. 1422 However, there are differences: For example, cultured synovia produce catabolin for over a week, 2131 whereas CCF is mainly produced over the first 3 days, in a pattern similar to that reported for cultured sclera. 18 As is the case for catabolin, 29 CCF production is dependent on continued protein synthesis ( Table 2 ). However, it is not known whether the prolonged production of catabolin by synovia reflects a greater resilience of these tissues to the culture conditions, as tissue viability studies similar to those reported here ( Figure 3 ) have not been conducted on porcine synovium. CCF-mediated resorption of proteoglycan in bovine nasal cartilage is a dose-dependent phenomenon, the pattern of response ( Figure 2 ) resembling that reported for other preparations of both human and porcine origin. 2 -810-' 8 -20 Furthermore, the kinetics of glycosaminoglycan release from cartilage discs are similar for both CCF and partially purified catabolin (Figure 1 ). Data presented elsewhere 6 -33 shows that not only do porcine mitral valves produce CCF but they also respond to its presence. This was demonstrated by the dose-dependent degradation of collagen in the presence of both crude and partially pure CCF. 33 Degradation of collagen in cartilage explants exposed to crude synovial products has also been reported. 30 However, similar experiments using pure leukocyte catabolin have failed to induce collagen degradation, despite stimulation33 of latent collagenase production. Thus, as it is thought that the synovial and leukocyte proteins are identical, the effect on collagen observed with crude and partially pure catabolin preparations may be an artifact attributable to contaminants, perhaps activating the latent collagenase. It is not yet known whether CCF is operating in a similar way.
It has been shown that corticosteroids suppress the production of catabolic factors by a variety of cells and tissues, 4 -71018 -213037 but the effect of these drugs on the biological activity of these factors is variable. Production of catabolin by cultured synovia was inhibited by 0.1 /Ag/ml cortisol succinate, 30 but similar concentrations had no effect on the cartilage-degrading activity of this protein 18 -21-30 consistent with the earlier report of Steinberg et al. 19 The cartilage catabolic activity derived from cultured bovine sclera was also shown to exhibit this differential response to steroid.' 8 As reported here, CCF behaves in a similar fashion in response to the presence of hydrocortisone succinate and methylprednisolone. In contrast, a number of workers have reported that cortisol inhibits cartilage matrix degradation and the secretion of proteolytic enzymes, mediated by cell-derived catabolic factors. 4 -10 -38 -39 However, Saklatvala et al 8 observed that the activity of crude leukocyte culture supernatants was inhibited by corti-sol but that the activity of the protein isolated from these preparations was not. It was suggested that this could arise either from the presence of more than one active component or that the action of catabolin was suppressed by cortisol in the presence of other substances in the original mixture. Therefore, differences in response to steroids that may, at first, lead one to suspect the presence of separate active molecules, may only be due to interferences caused by the use of impure preparations.
It has been reported that nonsteroidal anti-inflammatory drugs (NSAIDS) have variable effects on the production and action of these catabolic factors. 5 For example, Dingle 31 has shown that benoxaprofen markedly enhances the production of catabolin by cultured synovia. Others have reported that indomethacin suppressed cartilage degradation in synovium-cartilage co-cultures 39 contradicting reports claiming that NSAIDS fail to interfere with matrix breakdown. 5 ' 7 ' 921 None of the NSAIDS used in our experiments had any effect on the production of CCF nor on its activity in the cartilage bioassay. It is not clear why benoxaprofen did not amplify CCF production in the same way as described for synovial catabolin. 31 However, consideration of the differences in tissue architecture of cardiac valves and synovia may provide the most plausible explanation. Whereas the normal cardiac valve is a simple, fibrous structure, composed predominantly of collagen and fibroblasts, covered by a thin layer of endothelium, the synovium is much more complex. This tissue is composed of a variety of different cells, including monocytes, with an abundant vasculature. Thus, the opportunity for cell-cell cooperation in response to various stimuli is much greater in the synovium. The observed amplification of catabolin production by benoxaprofen, therefore, may well be mediated by cells that are not present in the cardiac valve.
Our observations show that cultured porcine heart valves are capable of producing a catabolic factor in response to tissue injury, arising from the dissection and mincing of the valves. These data show that CCF is similar to catabolin, both in its production and in the way it stimulates cells to degrade their extracellular matrix. When this data is taken together with biochemical evidence, estimating that CCF has a molecular weight of 20,000-22,000 daltons and isoelectric point of 5.2, 33 CCF can legitimately be classified as a catabolin-like molecule as defined by Saklatvala. 18 Recently, it has been shown that pure catabolin exhibits properties characteristic of interleukin-1, and on the basis of these data, it was suggested that catabolin is a form of interleukin-1. 35 CCF has also been shown to stimulate thymocyte proliferation, the defining activity of IL-1 33 ; furthermore, data presented here and elsewhere 33 shows that CCF activity can be effectively neutralized by preincubation with antisera raised to porcine IL-1. Even though this neutralization was only achieved at relatively high antiserum concentrations compared with those reported, 32 these studies imply that CCF is immunologically related to the lymphokine.
The data presented here and by Decker et al 33 suggest that CCF may be another form of interleukin-1 and, as such, may be highly relevant in the pathogenesis of inflammatory lesions within the normally avascular cardiac valve. Confirmation of the precise relation of CCF to IL-1 will first require the complete purification of the protein. In addition, recent advances made at the molecular level 40 should help to identify specific mRNAs which, when translated in vitro, exhibit biological activities characteristic of these cytokines.
